A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. - Cascone T; Sepesi B; Lin HY; Kalhor N; Parra ER; Jiang M; Godoy MCB; Zhang J; Fossella FV; Tsao AS; Lam VK; Lu C; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2020)